Prostate-specific Antigen Surveillance Among Men With Clinically Localized Prostate Cancer Who Do Not Receive Initial Treatment EDITORIAL COMMENT

被引：0
|
作者：
Gore, John L. [1 ]
机构：
[1] Univ Washington, Sch Med, Dept Urol, Seattle, WA 98195 USA
来源：
UROLOGY | 2011年 / 78卷 / 05期
关键词：
MANAGEMENT;
D O I：
10.1016/j.urology.2011.05.056
中图分类号：
R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：1113 / 1114
页数：3
相关论文
共 50 条
  • [41] The implications of prostate-specific antigen density to predict clinically significant prostate cancer in men <= 50 years
    Kosaka, Takeo
    Mizuno, Ryuichi
    Shinojima, Toshiaki
    Miyajima, Akira
    Kikuchi, Eiji
    Tanaka, Nobuyuki
    Shinoda, Kazunobu
    Morita, Shinya
    Mikami, Shuji
    Oya, Mototsugu
    [J]. AMERICAN JOURNAL OF CLINICAL AND EXPERIMENTAL UROLOGY, 2014, 2 (04): : 332 - 336
  • [42] Evaluation of changes in prostate specific antigen in clinically localized prostate cancer managed without initial therapy
    Gerber, GS
    Gornik, HL
    Goldfischer, ER
    Chodak, GW
    Rukstalis, DB
    [J]. JOURNAL OF UROLOGY, 1998, 159 (04): : 1243 - 1246
  • [43] The use of percent free prostate specific antigen for staging of men with clinically localized prostate cancer.
    Subong, E
    Pannek, J
    Chan, DW
    Epstein, JI
    Walsh, PC
    Partin, AW
    [J]. JOURNAL OF UROLOGY, 1998, 159 (05): : 294 - 294
  • [44] Editorial Comment to Effect of constipation on serum total prostate-specific antigen levels in men
    Averbeck, Marcio Augusto
    [J]. INTERNATIONAL JOURNAL OF UROLOGY, 2012, 19 (01) : 60 - 60
  • [45] Re: Prostate-Specific Antigen Velocity (PSAV) Risk Count Improves the Specificity of Screening for Clinically Significant Prostate Cancer Editorial Comment
    Walsh, Patrick C.
    [J]. JOURNAL OF UROLOGY, 2012, 188 (02): : 430 - 431
  • [46] Inferior Cancer Survival for Men with Localized High-grade Prostate Cancer but Low Prostate-specific Antigen
    Fankhauser, Christian D.
    Penney, Kathryn L.
    Gonzalez-Feliciano, Amparo G.
    Clarke, Noel W.
    Hermanns, Thomas
    Stopsack, Konrad H.
    Fiorentino, Michelangelo
    Loda, Massimo
    Mahal, Brandon
    Gerke, Travis A.
    Preston, Mark A.
    Mucci, Lorelei A.
    [J]. EUROPEAN UROLOGY, 2020, 78 (04) : 637 - +
  • [47] Changing prostate-specific antigen outcome after surgery or radiotherapy for localized prostate cancer during the prostate-specific antigen era
    D'Amico, AV
    Chen, MH
    Oh-Ung, J
    Renshaw, AA
    Cote, K
    Loffredo, M
    Richie, JP
    [J]. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2002, 54 (02): : 436 - 441
  • [48] Correlates of Bother Following Treatment for Clinically Localized Prostate Cancer EDITORIAL COMMENT
    Gacci, M.
    [J]. JOURNAL OF UROLOGY, 2010, 184 (04): : 1315 - 1315
  • [49] Survival Among Men With Clinically Localized Prostate Cancer Treated With Radical Prostatectomy or Radiation Therapy in the Prostate Specific Antigen Era
    Kibel, Adam S.
    Ciezki, Jay P.
    Klein, Eric A.
    Reddy, Chandana A.
    Lubahn, Jessica D.
    Haslag-Minoff, Jennifer
    Deasy, Joseph O.
    Michalski, Jeff M.
    Kallogjeri, Dorina
    Piccirillo, Jay F.
    Rabah, Danny M.
    Yu, Changhong
    Kattan, Michael W.
    Stephenson, Andrew J.
    [J]. JOURNAL OF UROLOGY, 2012, 187 (04): : 1259 - 1265
  • [50] Role of prostate-specific antigen velocity in prediction of final pathologic stage in men with localized prostate cancer
    Thiel, R
    Pearson, JD
    Epstein, JI
    Walsh, PC
    Carter, HB
    [J]. UROLOGY, 1997, 49 (05) : 716 - 720
12345